SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Kaldor Stephen W

(Last) (First) (Middle)
11975 EL CAMINO REAL, SUITE 101

(Street)
SAN DIEGO CA 91230

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
12/02/2020
3. Issuer Name and Ticker or Trading Symbol
Kinnate Biopharma Inc. [ KNTE ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 1,615,826 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) (1) 03/23/2030 Common Stock 256,328 $2.57 D
Stock Option (Right to Buy) (2) 08/18/2030 Common Stock 68,852 $5.63 D
Explanation of Responses:
1. The Option vests and becomes exercisable over time at the following rate: 170,885 of the total number of shares subject to the Option vested and became exercisable on August 20, 2020, and thereafter 1/20th of the remaining shares shall vest each month in equal installments on the first day of each month.
2. The Option vests and becomes exercisable over time at the following rate: 1/24th of the total number of shares subject to the Option shall vest monthly in equal installments over two years commencing on the one-month anniversary of August 1, 2020, the Vesting Commencement Date, and each month thereafter on the same day of the month as the Vesting Commencement Date.
Remarks:
Date set forth above represents the effective date of the issuer's initial public offering. Exhibit List: Exhibit 24 - Power of Attorney
/s/ Mark A. Meltz, attorney-in-fact 12/02/2020
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.